There is widespread consensus in industry that conventional screening libraries do not contain a large enough amount of three-dimensionality and 3D diversity. We believe that successful drug discovery requires more innovative screening decks.
We advance your libraries by including fused, bridged, and spirocyclic ring systems with an increased level of saturation. These additions cover an increased area of novel chemical space, allowing for richer compounds with superior intellectual property positioning.
Let's explore new chemical space together!